Balentine LLC’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,303
| Closed | -$207K | – | 209 |
|
|
2025
Q1 | $207K | Sell |
2,303
-700
| -23% | -$65.4K | 0.01% | 155 |
|
|
2024
Q4 | $299K | Sell |
3,003
-700
| -19% | -$72.2K | 0.01% | 112 |
|
|
2024
Q3 | $421K | Buy |
3,703
+725
| +24% | +$86.1K | 0.02% | 110 |
|
|
2024
Q2 | $369K | Sell |
2,978
-86,563
| -97% | -$11.2M | 0.02% | 87 |
|
|
2024
Q1 | $11.8M | Sell |
89,541
-3,446
| -4% | -$425K | 0.35% | 27 |
|
|
2023
Q4 | $10.1M | Sell |
92,987
-6,874
| -7% | -$714K | 0.32% | 32 |
|
|
2023
Q3 | $10.3M | Sell |
99,861
-1,507
| -1% | -$162K | 0.34% | 24 |
|
|
2023
Q2 | $11.7M | Sell |
101,368
-595
| -0.6% | -$67.6K | 0.39% | 23 |
|
|
2023
Q1 | $10.8M | Buy |
101,963
+528
| +0.5% | +$57K | 0.37% | 26 |
|
|
2022
Q4 | $11.3M | Buy |
101,435
+8,632
| +9% | +$882K | 0.39% | 24 |
|
|
2022
Q3 | $7.99M | Sell |
92,803
-32,555
| -26% | -$2.91M | 0.3% | 24 |
|
|
2022
Q2 | $11.4M | Buy |
125,358
+71,224
| +132% | +$6.31M | 0.42% | 28 |
|
|
2022
Q1 | $4.44M | Buy |
54,134
+30,714
| +131% | +$2.42M | 0.15% | 39 |
|
|
2021
Q4 | $1.79M | Buy |
23,420
+5,342
| +30% | +$425K | 0.06% | 52 |
|
|
2021
Q3 | $1.36M | Buy |
18,078
+8,402
| +87% | +$639K | 0.05% | 44 |
|
|
2021
Q2 | $753K | Buy |
9,676
+3,221
| +50% | +$240K | 0.03% | 59 |
|
|
2021
Q1 | $475K | Sell |
6,455
-642
| -9% | -$47.4K | 0.02% | 71 |
|
|
2020
Q4 | $554K | Sell |
7,097
-999
| -12% | -$76.4K | 0.03% | 60 |
|
|
2020
Q3 | $641K | Buy |
8,096
+3,693
| +84% | +$289K | 0.03% | 46 |
|
|
2020
Q2 | $325K | Buy |
4,403
+1,369
| +45% | +$103K | 0.02% | 63 |
|
|
2020
Q1 | $223K | Sell |
3,034
-5
| -0.2% | -$393 | 0.02% | 57 |
|
|
2019
Q4 | $264K | Buy |
3,039
+2,061
| +211% | +$169K | 0.01% | 59 |
|
|
2019
Q3 | $79K | Buy |
978
+361
| +59% | +$28.9K | ﹤0.01% | 107 |
|
|
2019
Q2 | $49K | Buy |
617
+290
| +89% | +$22.2K | ﹤0.01% | 112 |
|
|
2019
Q1 | $26K | Hold |
327
| – | – | ﹤0.01% | 178 |
|
|
2018
Q4 | $24K | Hold |
327
| – | – | ﹤0.01% | 175 |
|
|
2018
Q3 | $22K | Buy |
327
+95
| +41% | +$6.05K | ﹤0.01% | 132 |
|
|
2018
Q2 | $13K | Buy |
+232
| New | +$13.1K | ﹤0.01% | 83 |
|
|
2018
Q1 | – | Sell |
-2,356
| Closed | -$126K | – | 353 |
|
|
2017
Q4 | $126K | Sell |
2,356
-76
| -3% | -$4.21K | 0.01% | 172 |
|
|
2017
Q3 | $149K | Buy |
2,432
+224
| +10% | +$13.6K | 0.01% | 139 |
|
|
2017
Q2 | $135K | Buy |
2,208
+21
| +1% | +$1.28K | 0.01% | 134 |
|
|
2017
Q1 | $133K | Buy |
2,187
+45
| +2% | +$2.73K | 0.01% | 133 |
|
|
2016
Q4 | $120K | Hold |
2,142
| – | – | 0.01% | 132 |
|
|
2016
Q3 | $128K | Buy |
2,142
+977
| +84% | +$57.1K | 0.02% | 107 |
|
|
2016
Q2 | $64K | Buy |
1,165
+620
| +114% | +$33K | 0.01% | 138 |
|
|
2016
Q1 | $28K | Hold |
545
| – | – | 0.01% | 153 |
|
|
2015
Q4 | $27K | Buy |
545
+21
| +4% | +$1.06K | 0.01% | 218 |
|
|
2015
Q3 | $25K | Buy |
524
+105
| +25% | +$5.58K | ﹤0.01% | 260 |
|
|
2015
Q2 | $23K | Sell |
419
-757
| -64% | -$42.5K | ﹤0.01% | 251 |
|
|
2015
Q1 | $64K | Buy |
+1,176
| New | +$66.6K | 0.01% | 118 |
|
Other funds holding MRK
Balentine LLC's MRK Position: Q2 2025 in Review
Balentine LLC sold out of Merck (MRK) in Q2 2025, closing a stake of 2,303 shares — an estimated $207K sold.
Balentine LLC first reported a position in MRK in Q1 2015 and held it in 40 quarters. The position peaked at $11.8M in Q1 2024. 3,327 funds tracked by Wall St. Rank hold MRK as of Q2 2025.
- Balentine LLC reported no remaining Merck position as of Q2 2025 after selling out during the quarter.
- Balentine LLC sold 2,303 Merck shares in Q2 2025, an estimated $207K.
- Balentine LLC first reported a position in Merck in Q1 2015 and held it in 40 quarters.
- Balentine LLC's Merck position peaked at $11.8M in Q1 2024.
- 3,327 funds tracked by Wall St. Rank held Merck as of Q2 2025.
Based on Balentine LLC's 13F filing for Q2 2025, filed 4 Aug 2025.